US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

ARS PHARMACEUTICALS INC

12.49

-0.1400-1.11%

Post-market: 12.490.00000.00%17:03 EDT

Volume:1.19M

Turnover:14.83M

Market Cap:1.23B

PE:156.13

High:12.78

Open:12.63

Low:12.21

Close:12.63

Loading ...

Overview Company News Filings

BUZZ-U.S. STOCKS ON THE MOVE-CoreCivic, Teladoc, Dynavax

ARS Pharmaceuticals Shares up 1.6% on Expanded US Approval for Allergic Reaction Nasal Spray

THOMSON REUTERS

BUZZ-U.S. STOCKS ON THE MOVE-Scienture, ARS Pharma, BrightSpring Health

BUZZ-ARS Pharma rises on expanded US approval for allergic reaction nasal spray

Analysts Offer Insights on Healthcare Companies: ARS Pharmaceuticals (SPRY) and Corbus Pharmaceuticals (CRBP)

ARS Pharmaceuticals Says US FDA Approves Lower Dosage of Neffy Nasal Spray

MT Newswires Live

BRIEF-ARS Pharmaceuticals Announces FDA Approval of neffy® 1 mg (epinephrine nasal spray) for Type I Allergic Reactions

ARS Pharmaceuticals announces FDA approval for neffy 1 mg

US FDA expands use of ARS Pharma's allergic reaction nasal spray in 15-30 kg patients

US FDA expands use of allergic reaction nasal spray in people between 15-30 kilograms

ARS Pharmaceuticals Announces FDA Approval of Neffy® 1 Mg (Epinephrine Nasal Spray) for Type I Allergic Reactions, Including Anaphylaxis, in Pediatric Patients Weighing 15 to < 30 Kilograms

THOMSON REUTERS

ARS Pharmaceuticals: Most Commercially Insured Patients Will Pay No More Than $25 for Two Single-Use Neffy Devices Through a Co-Pay Savings Program

THOMSON REUTERS

ARS Pharmaceuticals Inc - Neffy 1 Mg Is Expected to Be Available in U.S. by End of May 2025

THOMSON REUTERS

ARS Pharmaceuticals Inc: IF Product Isn't Covered by Insurance, Cash Price of $199 for Two Doses Is Available Through Blinkrx

THOMSON REUTERS

3 Growth Companies With High Insider Ownership Growing Earnings Up To 61%

Simply Wall St.

ARS Pharmaceuticals Announces Conference Call and Webcast for its Fourth Quarter and Full Year 2024 Financial Results and Participation at Upcoming Conferences

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/SPRY/news?page=3"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"SPRY","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"SPRY\",,,,,undefined,":{"symbol":"SPRY","market":"US","secType":"STK","nameCN":"ARS PHARMACEUTICALS INC","latestPrice":12.49,"timestamp":1743192000000,"preClose":12.63,"halted":0,"volume":1191077,"hourTrading":{"tag":"盘后","latestPrice":12.49,"preClose":12.49,"latestTime":"17:03 EDT","volume":17143,"amount":214116.4,"timestamp":1743195804294},"delay":0,"floatShares":47453121,"shares":98119804,"eps":0.079999,"marketStatus":"Market Closed","change":-0.14,"latestTime":"03-28 16:00:00 EDT","open":12.63,"high":12.78,"low":12.21,"amount":14834809.245458001,"amplitude":0.045131,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":0.079999,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Market Trading","tradingStatus":1,"beginTime":1743408000000},"marketStatusCode":7,"adr":0,"listingDate":1607058000000,"exchange":"NASDAQ","adjPreClose":12.63,"preHourTrading":{"tag":"盘前","latestPrice":12.5701,"preClose":12.63,"latestTime":"09:14 EDT","volume":621,"amount":7813.0416374999995,"timestamp":1743167698692},"postHourTrading":{"tag":"盘后","latestPrice":12.49,"preClose":12.49,"latestTime":"17:03 EDT","volume":17143,"amount":214116.4,"timestamp":1743195804294},"volumeRatio":0.41667535412287643,"impliedVol":0.7288,"impliedVolPercentile":0.452},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"SPRY\",,,,,undefined,":{"symbol":"SPRY","floatShares":47453121,"roa":"-0.66%","roe":"3.28%","lyrEps":0.082507,"volumeRatio":0.41667535412287643,"shares":98119804,"dividePrice":0,"high":12.78,"amplitude":0.045131,"preClose":12.63,"low":12.21,"week52Low":7.55,"pbRate":"4.77","psRate":"13.75","week52High":18.51,"institutionHeld":0,"latestPrice":12.49,"eps":0.079999,"divideRate":0,"volume":1191077,"delay":0,"ttmEps":0.079999,"open":12.63,"prevYearClose":10.55,"prevWeekClose":12.36,"prevMonthClose":10.48,"prevQuarterClose":10.55,"fiveDayClose":12.36,"twentyDayClose":10.48,"sixtyDayClose":10.62},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"SPRY\",pageSize:16,pageCount:3,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2517216456","title":"BUZZ-U.S. STOCKS ON THE MOVE-CoreCivic, Teladoc, Dynavax","url":"https://stock-news.laohu8.com/highlight/detail?id=2517216456","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517216456?lang=en_us&edition=fundamental","pubTime":"2025-03-06 23:41","pubTimestamp":1741275681,"startTime":"0","endTime":"0","summary":"BUZZ-U.S. STOCKS ON THE MOVE-CoreCivic, Teladoc, DynavaxEikon search string for individual stock moves: STXBZThe Day Ahead newsletter: https://refini.tv/3LI4BU7The Morning News Call newsletter: https:","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250306:nL3N3PP1CU:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1223082196.USD","LU1267930573.SGD","DVAX","IE00BKVL7J92.USD","LU0149725797.USD","CZR","CPB","FCX","IE00BJTD4N35.SGD","HTGC","KR","NEM","LU0648001328.SGD","LU1699723380.USD","FAST","LU1496350171.SGD","MRVL","VG","DHI","BTSG","LULU","TDOC","CXW","IBRX","ALGM","KBH","BAC","BK4543","LEN","SCNX","LU1366192091.USD","LU2552382215.SGD","BK4560","PHM","LU0820561818.USD","MDB","BURL","ZS","LU2023250843.SGD","HUT","MOS","SPRY","IE00BJTD4V19.USD","VSCO"],"gpt_icon":1},{"id":"2517716308","title":"ARS Pharmaceuticals Shares up 1.6% on Expanded US Approval for Allergic Reaction Nasal Spray","url":"https://stock-news.laohu8.com/highlight/detail?id=2517716308","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517716308?lang=en_us&edition=fundamental","pubTime":"2025-03-06 22:36","pubTimestamp":1741271802,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250306:nFWN3PP1HD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["SPRY","BK4139"],"gpt_icon":0},{"id":"2517168920","title":"BUZZ-U.S. STOCKS ON THE MOVE-Scienture, ARS Pharma, BrightSpring Health","url":"https://stock-news.laohu8.com/highlight/detail?id=2517168920","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517168920?lang=en_us&edition=fundamental","pubTime":"2025-03-06 22:09","pubTimestamp":1741270157,"startTime":"0","endTime":"0","summary":"BUZZ-U.S. STOCKS ON THE MOVE-Scienture, ARS Pharma, BrightSpring HealthEikon search string for individual stock moves: STXBZThe Day Ahead newsletter: https://refini.tv/3LI4BU7The Morning News Call new","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"e5c43d65b893d390fb338910195c4df7","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250306:nL6N3PP0KV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0320765489.SGD","IE00B7SZLL34.SGD","SPRY","LU2028103732.USD","ALGM","LU2237443978.SGD","FCX","LU1883839398.USD","LU2756315318.SGD","SCNX","LU1914381329.SGD","MDB","LU1989764748.USD","IE00BZ1G4Q59.USD","CPB","LU0648001328.SGD","LU2237438978.USD","LU0708994859.HKD","IE00BMPRXN33.USD","LU2125909916.SGD","ZS","BURL","LU0788109121.HKD","IE00BBT3K403.USD","LU0719512351.SGD","BAC","LU0082616367.USD","IE00BHPRN162.USD","IBRX","LU1506573853.SGD","BK4604","LU2089284900.SGD","BK4560","LU0048584097.USD","LU1732800096.USD","NEM","LU2750360997.AUD","LU2360107168.USD","LU1244550577.SGD","VSCO","LU2498475776.HKD","LU0971096721.USD","LU2471134523.USD","LU0330918003.SGD","LU2430703251.USD","BTSG","KKR","IE00B64PRP62.GBP"],"gpt_icon":1},{"id":"2517157459","title":"BUZZ-ARS Pharma rises on expanded US approval for allergic reaction nasal spray","url":"https://stock-news.laohu8.com/highlight/detail?id=2517157459","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517157459?lang=en_us&edition=fundamental","pubTime":"2025-03-06 21:37","pubTimestamp":1741268277,"startTime":"0","endTime":"0","summary":"BUZZ-ARS Pharma rises on expanded US approval for allergic reaction nasal spray** Shares of drug developer ARS Pharmaceuticals SPRY.O rise 2.6% to $11.15 premarket** Co said late on Wednesday the U.S. FDA approved the expanded use of nasal spray for severe allergic reactions in patients who weigh between 15 kg and 30 kg** The spray, sold under the brand name neffy, will be dosed at 1 mg for the new patient population** Neffy is designed to be given at the first sign of a severe allergic reaction, and has been previously approved for people above 30 kg at dose of 2 mg** SPRY has risen 21.5% in the past 12 months  ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250306:nL3N3PP0VF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SPRY","BK4139"],"gpt_icon":0},{"id":"2517158621","title":"Analysts Offer Insights on Healthcare Companies: ARS Pharmaceuticals (SPRY) and Corbus Pharmaceuticals (CRBP)","url":"https://stock-news.laohu8.com/highlight/detail?id=2517158621","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517158621?lang=en_us&edition=fundamental","pubTime":"2025-03-06 19:00","pubTimestamp":1741258816,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on ARS Pharmaceuticals (SPRY – Research Report) and Cor...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-ars-pharmaceuticals-spry-and-corbus-pharmaceuticals-crbp?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-ars-pharmaceuticals-spry-and-corbus-pharmaceuticals-crbp?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["CRBP","HCSG","SPRY","BK4139","BK4137"],"gpt_icon":0},{"id":"2517209939","title":"ARS Pharmaceuticals Says US FDA Approves Lower Dosage of Neffy Nasal Spray","url":"https://stock-news.laohu8.com/highlight/detail?id=2517209939","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517209939?lang=en_us&edition=fundamental","pubTime":"2025-03-06 06:37","pubTimestamp":1741214262,"startTime":"0","endTime":"0","summary":"ARS Pharmaceuticals  said the US Food and Drug Administration approved a lower dosage of neffy for allergic emergencies, including anaphylaxis.The regulator approved a 1 milligram version of the nasal spray for children 4 years and up, the company said Wednesday in a statement.A 2 mg version of neffy, an epinephrine nasal spray, was approved in the US in 2024.ARS shares rose 5.1% in after-hours trading.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["SPRY","BK4139"],"gpt_icon":0},{"id":"2517927311","title":"BRIEF-ARS Pharmaceuticals Announces FDA Approval of neffy® 1 mg (epinephrine nasal spray) for Type I Allergic Reactions","url":"https://stock-news.laohu8.com/highlight/detail?id=2517927311","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517927311?lang=en_us&edition=fundamental","pubTime":"2025-03-06 06:09","pubTimestamp":1741212595,"startTime":"0","endTime":"0","summary":"BRIEF-ARS Pharmaceuticals Announces FDA Approval of neffy 1 mg (epinephrine nasal spray) for Type I Allergic ReactionsMarch 5 (Reuters) - ARS Pharmaceuticals Inc SPRY.O:ARS PHARMACEUTICALS ANNOUNCES F","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250305:nTUA4R29QJ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SPRY","BK4139"],"gpt_icon":0},{"id":"2517922253","title":"ARS Pharmaceuticals announces FDA approval for neffy 1 mg","url":"https://stock-news.laohu8.com/highlight/detail?id=2517922253","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517922253?lang=en_us&edition=fundamental","pubTime":"2025-03-06 05:46","pubTimestamp":1741211185,"startTime":"0","endTime":"0","summary":"ARS Pharmaceuticals (SPRY) announced that the FDA has approved neffy 1 mg for the treatment of Type I Allergic Reactions, including anaphylaxis, in...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/ars-pharmaceuticals-announces-fda-approval-for-neffy-1-mg?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/ars-pharmaceuticals-announces-fda-approval-for-neffy-1-mg?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["SPRY","BK4139"],"gpt_icon":0},{"id":"2517212219","title":"US FDA expands use of ARS Pharma's allergic reaction nasal spray in 15-30 kg patients","url":"https://stock-news.laohu8.com/highlight/detail?id=2517212219","media":"Reuters","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517212219?lang=en_us&edition=fundamental","pubTime":"2025-03-06 05:21","pubTimestamp":1741209694,"startTime":"0","endTime":"0","summary":"UPDATE 2-US FDA expands use of ARS Pharma's allergic reaction nasal spray in 15-30 kg patientsAdds analyst comments in paragraphs 7-9; CEO comments in paragraphs 11 & 12 and details throughoutBy Chris","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250305:nL3N3PO1TS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4007","BK4585","BK4588","VTRS","BK4583","SPRY","LU2087621335.USD","LU1839511570.USD"],"gpt_icon":0},{"id":"2517921969","title":"US FDA expands use of allergic reaction nasal spray in people between 15-30 kilograms","url":"https://stock-news.laohu8.com/highlight/detail?id=2517921969","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517921969?lang=en_us&edition=fundamental","pubTime":"2025-03-06 05:14","pubTimestamp":1741209258,"startTime":"0","endTime":"0","summary":"US FDA expands use of allergic reaction nasal spray in people between 15-30 kilogramsMarch 5  - The U.S. Food and Drug Administration approved the expanded use of ARS Pharmaceuticals' SPRY.O nasal spray for severe allergic reactions in patients who weigh between 15 to 30 kilograms, the company said on Wednesday.   ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250305:nL3N3PO1TM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","LU1839511570.USD","BK4585","BK4583","BK4007","BK4139","VTRS","SPRY","LU2087621335.USD"],"gpt_icon":0},{"id":"2517921573","title":"ARS Pharmaceuticals Announces FDA Approval of Neffy® 1 Mg (Epinephrine Nasal Spray) for Type I Allergic Reactions, Including Anaphylaxis, in Pediatric Patients Weighing 15 to < 30 Kilograms","url":"https://stock-news.laohu8.com/highlight/detail?id=2517921573","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517921573?lang=en_us&edition=fundamental","pubTime":"2025-03-06 05:10","pubTimestamp":1741209000,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250305:nTUA4R29QJ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["SPRY","BK4139"],"gpt_icon":0},{"id":"2517921572","title":"ARS Pharmaceuticals: Most Commercially Insured Patients Will Pay No More Than $25 for Two Single-Use Neffy Devices Through a Co-Pay Savings Program","url":"https://stock-news.laohu8.com/highlight/detail?id=2517921572","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517921572?lang=en_us&edition=fundamental","pubTime":"2025-03-06 05:10","pubTimestamp":1741209000,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250305:nTUA4R29QJ:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","SPRY"],"gpt_icon":0},{"id":"2517492157","title":"ARS Pharmaceuticals Inc - Neffy 1 Mg Is Expected to Be Available in U.S. by End of May 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2517492157","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517492157?lang=en_us&edition=fundamental","pubTime":"2025-03-06 05:10","pubTimestamp":1741209000,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250305:nTUA4R29QJ:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","SPRY"],"gpt_icon":0},{"id":"2517216899","title":"ARS Pharmaceuticals Inc:  IF Product Isn't Covered by Insurance, Cash Price of $199 for Two Doses Is Available Through Blinkrx","url":"https://stock-news.laohu8.com/highlight/detail?id=2517216899","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517216899?lang=en_us&edition=fundamental","pubTime":"2025-03-06 05:10","pubTimestamp":1741209000,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250305:nTUA4R29QJ:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["SPRY","BK4139"],"gpt_icon":0},{"id":"2517294278","title":"3 Growth Companies With High Insider Ownership Growing Earnings Up To 61%","url":"https://stock-news.laohu8.com/highlight/detail?id=2517294278","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517294278?lang=en_us&edition=fundamental","pubTime":"2025-03-06 01:05","pubTimestamp":1741194344,"startTime":"0","endTime":"0","summary":"In the current U.S. market environment, investors are navigating mixed signals as they await news on tariffs and digest fresh economic data, with major indices reflecting a cautious sentiment amid broader economic concerns. In such times, companies that showcase high insider ownership coupled with strong earnings growth can be particularly appealing, as insider stakes often indicate confidence in the company's future prospects.Top 10 Growth Companies With High Insider Ownership In The United States. Click here to see the full list of 202 stocks from our Fast Growing US Companies With High Insider Ownership screener.OPAL Fuels is experiencing strategic growth, highlighted by joint ventures to develop landfill RNG projects and the acquisition of a fueling station in California. The company expects earnings growth of 29.24% annually, surpassing the US market average. However, profit margins have decreased from 8.7% to 1.6%, and interest payments are not well covered by earnings. Recent ex","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/3-growth-companies-high-insider-170544341.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["SPRY","OPAL","TIGR"],"gpt_icon":1},{"id":"2516366964","title":"ARS Pharmaceuticals Announces Conference Call and Webcast for its Fourth Quarter and Full Year 2024 Financial Results and Participation at Upcoming Conferences","url":"https://stock-news.laohu8.com/highlight/detail?id=2516366964","media":"GlobeNewswire","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516366964?lang=en_us&edition=fundamental","pubTime":"2025-03-04 05:35","pubTimestamp":1741037700,"startTime":"0","endTime":"0","summary":"Company to Host Conference Call on March 20 at 8:30 a.m. ET. In addition, ARS Pharma Management will be participating in several upcoming investor conferences:. Leerink Partners Global Healthcare Conference: fireside chat on March 10, 2025. 37thAnnual Roth Conference: investor meetings on March 16-18, 2025. To access the webcast and slides, please visit the Events & Presentations page in the Investors & Media section of the Company’s website. A replay of the webcast will be available for 30 days following the event.About ARS Pharmaceuticals, Inc. ARS Pharmaceuticals is a biopharmaceutical company dedicated to empowering at-risk patients and their caregivers to better protect patients from allergic reactions that could lead to anaphylaxis. The company is commercializing neffy 2 mg  , an epinephrine nasal spray indicated in the U.S. for emergency treatment of Type I allergic reactions, including anaphylaxis, in adult and pediatric patients who weigh 30 kg or greater, and in the EU for em","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/ars-pharmaceuticals-announces-conference-call-213500429.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4139","SPRY"],"gpt_icon":0}],"pageSize":16,"totalPage":8,"pageCount":3,"totalSize":116}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/SPRY\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-03-20","symbol":"SPRY","fiscalQuarterEnding":"2024/12","expectedEps":-0.04,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1742443200000,"reportTimeType":"pre","actualEps":0.52},{"market":"US","date":"2025-01-13","symbol":"SPRY","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1736744400000,"reportTimeType":"pre","actualEps":null},{"market":"US","date":"2024-11-13","symbol":"SPRY","fiscalQuarterEnding":"2024/09","expectedEps":-0.18,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1731474000000,"reportTimeType":"pre","actualEps":-0.2},{"market":"US","date":"2024-08-06","symbol":"SPRY","fiscalQuarterEnding":"2024/06","expectedEps":-0.12,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1722916800000,"reportTimeType":"post","actualEps":-0.13},{"market":"US","date":"2024-05-09","symbol":"SPRY","fiscalQuarterEnding":"2024/03","expectedEps":-0.11,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1715227200000,"reportTimeType":"post","actualEps":-0.11}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"SPRY\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"SPRY\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.6667,"buy":0.3333,"hold":0,"sell":0,"strongSell":0,"meanLabel":"STRONG BUY","meanPercent":0.6667,"analysts":6,"updateTime":1741320000000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/SPRY\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"SPRY","date":"2025-03-28","current":154.945377,"percent":0.994604,"low":-41.829007,"twenty":-28.717849,"median":-17.742813,"eighty":-12.566149,"high":175.555688,"avg":-18.275476,"sd":20.407038,"marketCap":1239253124},"quantilePoints":[{"date":"2022-11-11","current":-28.534516,"twenty":-28.349227,"median":-28.071294,"eighty":-27.904534,"marketCap":577624216},{"date":"2022-11-18","current":-27.515427,"twenty":-28.349227,"median":-28.00181,"eighty":-27.867476,"marketCap":556994780},{"date":"2022-11-25","current":-28.627161,"twenty":-29.164499,"median":-28.302905,"eighty":-27.978649,"marketCap":579499619},{"date":"2022-12-02","current":-32.332942,"twenty":-29.813011,"median":-28.534516,"eighty":-27.978649,"marketCap":654515751},{"date":"2022-12-09","current":-33.352032,"twenty":-32.629404,"median":-28.951417,"eighty":-27.987913,"marketCap":675145188},{"date":"2022-12-16","current":-37.428392,"twenty":-33.870842,"median":-29.970507,"eighty":-28.034236,"marketCap":757662933},{"date":"2022-12-23","current":-37.428392,"twenty":-36.761351,"median":-31.221208,"eighty":-28.136145,"marketCap":757662933},{"date":"2022-12-30","current":-39.512894,"twenty":-37.428392,"median":-32.842487,"eighty":-28.39555,"marketCap":799859507},{"date":"2023-01-06","current":-33.490999,"twenty":-37.558094,"median":-33.236227,"eighty":-28.506723,"marketCap":677958292},{"date":"2023-01-13","current":-34.510089,"twenty":-37.428392,"median":-33.352032,"eighty":-28.608632,"marketCap":698587729},{"date":"2023-01-20","current":-24.704541,"twenty":-37.261632,"median":-32.981454,"eighty":-28.089644,"marketCap":627322403},{"date":"2023-01-27","current":-23.338221,"twenty":-36.955904,"median":-32.518231,"eighty":-27.978649,"marketCap":592627442},{"date":"2023-02-03","current":-26.292426,"twenty":-36.631648,"median":-30.109473,"eighty":-26.233342,"marketCap":667643574},{"date":"2023-02-10","current":-28.323442,"twenty":-36.44636,"median":-29.576768,"eighty":-26.233342,"marketCap":719217165},{"date":"2023-02-17","current":-31.868488,"twenty":-36.103575,"median":-29.970507,"eighty":-27.026227,"marketCap":809236523},{"date":"2023-02-24","current":-30.539096,"twenty":-35.51065,"median":-30.109473,"eighty":-27.543213,"marketCap":775479264},{"date":"2023-03-03","current":-33.641011,"twenty":-34.760229,"median":-30.612951,"eighty":-27.668279,"marketCap":854246203},{"date":"2023-03-10","current":-29.025066,"twenty":-34.306271,"median":-30.649879,"eighty":-27.867476,"marketCap":737033496},{"date":"2023-03-17","current":-31.056082,"twenty":-33.963486,"median":-30.631415,"eighty":-27.978649,"marketCap":788607087},{"date":"2023-03-24","current":-20.659679,"twenty":-33.801144,"median":-30.612951,"eighty":-27.867476,"marketCap":716518982},{"date":"2023-03-31","current":-17.719962,"twenty":-33.618064,"median":-30.576023,"eighty":-26.2038,"marketCap":614563712},{"date":"2023-04-06","current":-15.732931,"twenty":-33.565575,"median":-30.176574,"eighty":-25.70897,"marketCap":545649501},{"date":"2023-04-14","current":-16.631178,"twenty":-33.492841,"median":-29.970507,"eighty":-24.113699,"marketCap":576802501},{"date":"2023-04-21","current":-17.973502,"twenty":-33.463206,"median":-29.344076,"eighty":-23.419462,"marketCap":623356984},{"date":"2023-04-28","current":-17.210989,"twenty":-33.352032,"median":-29.090384,"eighty":-19.070054,"marketCap":596911536},{"date":"2023-05-05","current":-16.693286,"twenty":-33.350744,"median":-28.918758,"eighty":-18.073817,"marketCap":578956528},{"date":"2023-05-12","current":-12.329028,"twenty":-33.323434,"median":-28.627161,"eighty":-17.841072,"marketCap":427595344},{"date":"2023-05-19","current":-17.294264,"twenty":-33.212652,"median":-28.359496,"eighty":-17.789501,"marketCap":733155735},{"date":"2023-05-26","current":-17.057707,"twenty":-33.123305,"median":-28.101877,"eighty":-17.789501,"marketCap":723127390},{"date":"2023-06-02","current":-15.358643,"twenty":-33.120421,"median":-28.024971,"eighty":-17.719962,"marketCap":651098973},{"date":"2023-06-09","current":-15.179795,"twenty":-32.981454,"median":-27.978649,"eighty":-17.665522,"marketCap":643517035},{"date":"2023-06-16","current":-13.525443,"twenty":-32.939388,"median":-27.584891,"eighty":-17.230009,"marketCap":573384103},{"date":"2023-06-23","current":-14.352619,"twenty":-32.898926,"median":-26.292426,"eighty":-16.984823,"marketCap":608450569},{"date":"2023-06-30","current":-14.777385,"twenty":-32.852687,"median":-26.033933,"eighty":-16.443167,"marketCap":626457673},{"date":"2023-07-07","current":-14.374975,"twenty":-32.778571,"median":-25.664657,"eighty":-16.200645,"marketCap":609398311},{"date":"2023-07-14","current":-15.381,"twenty":-32.650157,"median":-24.815323,"eighty":-15.896248,"marketCap":652046716},{"date":"2023-07-20","current":-16.342312,"twenty":-32.522678,"median":-23.947525,"eighty":-15.738555,"marketCap":692799635},{"date":"2023-07-28","current":-14.889165,"twenty":-32.268091,"median":-23.449004,"eighty":-15.666005,"marketCap":631196385},{"date":"2023-08-04","current":-15.649273,"twenty":-31.980646,"median":-22.434463,"eighty":-15.664922,"marketCap":663419624},{"date":"2023-08-11","current":-12.27233,"twenty":-31.772476,"median":-20.321699,"eighty":-15.577733,"marketCap":654642902},{"date":"2023-08-18","current":-12.05734,"twenty":-31.358888,"median":-18.902086,"eighty":-15.443597,"marketCap":643174706},{"date":"2023-08-25","current":-12.361909,"twenty":-31.218563,"median":-18.499284,"eighty":-15.287104,"marketCap":659421318},{"date":"2023-08-30","current":-12.70231,"twenty":-31.152094,"median":-18.359623,"eighty":-15.152968,"marketCap":677579296},{"date":"2023-09-08","current":-13.114373,"twenty":-31.100395,"median":-18.231502,"eighty":-15.005417,"marketCap":699560007},{"date":"2023-09-15","current":-13.04271,"twenty":-31.033926,"median":-18.031385,"eighty":-14.777385,"marketCap":695737274},{"date":"2023-09-20","current":-11.833393,"twenty":-31.022847,"median":-18.002563,"eighty":-14.750557,"marketCap":631228667},{"date":"2023-09-27","current":-6.718429,"twenty":-31.011769,"median":-17.988032,"eighty":-14.670075,"marketCap":358381151},{"date":"2023-10-05","current":-7.166324,"twenty":-30.867751,"median":-17.964938,"eighty":-14.419687,"marketCap":382273228},{"date":"2023-10-13","current":-6.718429,"twenty":-30.668342,"median":-17.875755,"eighty":-14.196126,"marketCap":358381151},{"date":"2023-10-20","current":-6.055544,"twenty":-30.649879,"median":-17.782874,"eighty":-14.047454,"marketCap":323020877},{"date":"2023-10-27","current":-6.306365,"twenty":-30.649879,"median":-17.728408,"eighty":-14.012806,"marketCap":336400440},{"date":"2023-11-03","current":-6.539271,"twenty":-30.635108,"median":-17.710569,"eighty":-13.713234,"marketCap":348824320},{"date":"2023-11-10","current":-5.319172,"twenty":-30.612951,"median":-17.665522,"eighty":-13.225451,"marketCap":327799293},{"date":"2023-11-17","current":-7.025405,"twenty":-30.612951,"median":-17.36121,"eighty":-12.859969,"marketCap":432947606},{"date":"2023-11-24","current":-7.41484,"twenty":-30.59818,"median":-17.220775,"eighty":-12.627063,"marketCap":456946919},{"date":"2023-12-01","current":-7.523882,"twenty":-30.480012,"median":-17.057707,"eighty":-12.494486,"marketCap":463666727},{"date":"2023-12-08","current":-8.1314,"twenty":-30.216835,"median":-16.553813,"eighty":-12.335604,"marketCap":501105655},{"date":"2023-12-15","current":-8.115823,"twenty":-30.090944,"median":-16.431736,"eighty":-12.243664,"marketCap":500145682},{"date":"2023-12-22","current":-7.944471,"twenty":-30.007565,"median":-16.309818,"eighty":-8.996418,"marketCap":489585985},{"date":"2023-12-29","current":-8.770073,"twenty":-29.979771,"median":-16.222884,"eighty":-8.287174,"marketCap":540464528},{"date":"2024-01-05","current":-8.785651,"twenty":-29.917293,"median":-16.174641,"eighty":-8.399331,"marketCap":541424501},{"date":"2024-01-12","current":-9.112776,"twenty":-29.704533,"median":-16.005127,"eighty":-8.58626,"marketCap":561583924},{"date":"2024-01-19","current":-9.471056,"twenty":-29.440705,"median":-15.977907,"eighty":-8.629876,"marketCap":583663292},{"date":"2024-01-26","current":-10.156461,"twenty":-29.180978,"median":-15.857321,"eighty":-8.707763,"marketCap":625902083},{"date":"2024-02-02","current":-9.969533,"twenty":-29.156298,"median":-15.732931,"eighty":-8.773189,"marketCap":614382412},{"date":"2024-02-09","current":-10.109729,"twenty":-29.07732,"median":-15.682807,"eighty":-8.798113,"marketCap":623022165},{"date":"2024-02-16","current":-11.309188,"twenty":-29.025066,"median":-15.649273,"eighty":-8.900923,"marketCap":696940049},{"date":"2024-02-23","current":-11.83882,"twenty":-29.025066,"median":-15.515136,"eighty":-9.112776,"marketCap":729579115},{"date":"2024-03-01","current":-13.038279,"twenty":-28.81245,"median":-15.453657,"eighty":-9.20624,"marketCap":803496999},{"date":"2024-03-08","current":-13.941768,"twenty":-28.8035,"median":-15.381,"eighty":-9.20624,"marketCap":859175405},{"date":"2024-03-15","current":-14.019655,"twenty":-28.627161,"median":-15.258041,"eighty":-9.237395,"marketCap":863975268},{"date":"2024-03-22","current":-15.975609,"twenty":-28.534516,"median":-15.179795,"eighty":-9.252972,"marketCap":868513986},{"date":"2024-03-28","current":-17.679674,"twenty":-28.423343,"median":-15.269219,"eighty":-9.315282,"marketCap":961155477},{"date":"2024-04-05","current":-16.916395,"twenty":-28.337864,"median":-15.369822,"eighty":-9.405631,"marketCap":919659809},{"date":"2024-04-12","current":-16.401625,"twenty":-28.264358,"median":-15.43689,"eighty":-9.46171,"marketCap":891674358},{"date":"2024-04-19","current":-14.981571,"twenty":-28.131419,"median":-15.49278,"eighty":-9.483518,"marketCap":814473115},{"date":"2024-04-26","current":-14.360297,"twenty":-28.077411,"median":-15.403356,"eighty":-9.636176,"marketCap":780697571},{"date":"2024-05-03","current":-16.860498,"twenty":-28.034236,"median":-15.420123,"eighty":-9.72341,"marketCap":916620967},{"date":"2024-05-10","current":-17.157732,"twenty":-27.987913,"median":-15.505955,"eighty":-9.779488,"marketCap":852670667},{"date":"2024-05-17","current":-17.742813,"twenty":-27.978649,"median":-15.537492,"eighty":-9.809086,"marketCap":881746829},{"date":"2024-05-24","current":-17.157885,"twenty":-27.978649,"median":-15.649273,"eighty":-9.876069,"marketCap":852678252},{"date":"2024-05-31","current":-17.372359,"twenty":-27.867476,"median":-15.716341,"eighty":-9.910338,"marketCap":863336730},{"date":"2024-06-07","current":-17.19688,"twenty":-27.668279,"median":-15.746992,"eighty":-9.932147,"marketCap":854616157},{"date":"2024-06-14","current":-17.430851,"twenty":-27.557105,"median":-15.857321,"eighty":-9.95084,"marketCap":866243588},{"date":"2024-06-21","current":-15.071642,"twenty":-27.270827,"median":-15.857321,"eighty":-9.975764,"marketCap":749000328},{"date":"2024-06-28","current":-15.695565,"twenty":-26.781626,"median":-15.857321,"eighty":-9.988225,"marketCap":780006810},{"date":"2024-07-05","current":-17.723315,"twenty":-26.233342,"median":-15.924221,"eighty":-10.038073,"marketCap":880777877},{"date":"2024-07-12","current":-21.66183,"twenty":-26.100403,"median":-16.005127,"eighty":-10.100383,"marketCap":1076506294},{"date":"2024-07-15","current":-22.129772,"twenty":-26.078246,"median":-16.005127,"eighty":-10.103498,"marketCap":1099761155},{"date":"2024-08-02","current":-20.452979,"twenty":-26.05609,"median":-16.005127,"eighty":-10.106614,"marketCap":1016431235},{"date":"2024-08-09","current":-21.380681,"twenty":-25.915765,"median":-16.072487,"eighty":-10.122191,"marketCap":958752513},{"date":"2024-08-16","current":-29.271428,"twenty":-26.174258,"median":-16.163463,"eighty":-10.15023,"marketCap":1312589385},{"date":"2024-08-23","current":-27.693279,"twenty":-27.713295,"median":-16.214626,"eighty":-10.468009,"marketCap":1241822011},{"date":"2024-08-30","current":-28.060793,"twenty":-27.98643,"median":-16.295121,"eighty":-10.844982,"marketCap":1258302084},{"date":"2024-09-06","current":-25.401719,"twenty":-27.994212,"median":-16.393243,"eighty":-10.985179,"marketCap":1139063905},{"date":"2024-09-13","current":-27.304146,"twenty":-27.978649,"median":-16.401625,"eighty":-11.047488,"marketCap":1224372521},{"date":"2024-09-20","current":-32.125068,"twenty":-28.0393,"median":-16.454093,"eighty":-11.125375,"marketCap":1440552309},{"date":"2024-09-27","current":-31.368421,"twenty":-28.102738,"median":-16.474539,"eighty":-11.25311,"marketCap":1406622746},{"date":"2024-10-04","current":-30.265879,"twenty":-28.279129,"median":-16.592455,"eighty":-11.496117,"marketCap":1357182526},{"date":"2024-10-11","current":-30.071312,"twenty":-28.572704,"median":-16.658407,"eighty":-11.620736,"marketCap":1348457781},{"date":"2024-10-18","current":-34.870616,"twenty":-28.814446,"median":-16.809891,"eighty":-11.676815,"marketCap":1563668153},{"date":"2024-10-25","current":-33.292466,"twenty":-29.051193,"median":-16.869409,"eighty":-11.785716,"marketCap":1492900778},{"date":"2024-10-31","current":-30.849578,"twenty":-29.236068,"median":-16.900657,"eighty":-11.835564,"marketCap":1383356760},{"date":"2024-11-08","current":-34.892234,"twenty":-29.613,"median":-17.040899,"eighty":-11.890396,"marketCap":1564637569},{"date":"2024-11-15","current":-27.926178,"twenty":-29.784002,"median":-17.157809,"eighty":-12.003593,"marketCap":1371287052},{"date":"2024-11-22","current":-26.481379,"twenty":-29.677856,"median":-17.19688,"eighty":-12.129003,"marketCap":1300341655},{"date":"2024-11-29","current":-28.717849,"twenty":-29.625971,"median":-17.210989,"eighty":-12.243664,"marketCap":1410161242},{"date":"2024-12-06","current":-27.708469,"twenty":-29.56544,"median":-17.223194,"eighty":-12.275913,"marketCap":1360596650},{"date":"2024-12-13","current":-25.016789,"twenty":-29.525705,"median":-17.313866,"eighty":-12.298002,"marketCap":1228424404},{"date":"2024-12-20","current":-22.404276,"twenty":-29.458385,"median":-17.352861,"eighty":-12.329028,"marketCap":1100139577},{"date":"2024-12-27","current":-22.067816,"twenty":-29.271428,"median":-17.394358,"eighty":-12.329028,"marketCap":1083618046},{"date":"2025-01-03","current":-21.196979,"twenty":-29.200708,"median":-17.429503,"eighty":-12.355333,"marketCap":1040856437},{"date":"2025-01-10","current":-22.621986,"twenty":-29.176877,"median":-17.469847,"eighty":-12.383408,"marketCap":1110829979},{"date":"2025-01-17","current":-24.106368,"twenty":-29.123341,"median":-17.508842,"eighty":-12.41924,"marketCap":1183719085},{"date":"2025-01-24","current":-27.490759,"twenty":-29.064257,"median":-17.592246,"eighty":-12.455071,"marketCap":1349906247},{"date":"2025-01-31","current":-28.28243,"twenty":-29.064257,"median":-17.626125,"eighty":-12.501652,"marketCap":1388780437},{"date":"2025-02-07","current":-25.333457,"twenty":-29.025066,"median":-17.679674,"eighty":-12.537484,"marketCap":1243974080},{"date":"2025-02-14","current":-23.591782,"twenty":-29.002547,"median":-17.701176,"eighty":-12.573316,"marketCap":1158450862},{"date":"2025-02-21","current":-23.314697,"twenty":-28.938503,"median":-17.719962,"eighty":-12.598398,"marketCap":1144844895},{"date":"2025-02-28","current":-20.187599,"twenty":-28.816442,"median":-17.723315,"eighty":-12.627063,"marketCap":991291845},{"date":"2025-03-07","current":-21.355313,"twenty":-28.81066,"median":-17.742813,"eighty":-12.687977,"marketCap":1048631275},{"date":"2025-03-14","current":-23.651157,"twenty":-28.793317,"median":-17.742813,"eighty":-12.709476,"marketCap":1161366426},{"date":"2025-03-21","current":175.555688,"twenty":-28.745638,"median":-17.756493,"eighty":-12.709476,"marketCap":1404094395},{"date":"2025-03-28","current":154.945377,"twenty":-28.717849,"median":-17.742813,"eighty":-12.566149,"marketCap":1239253124}],"updateTime":1743240930647}}}